OCTOPOD-IV (NCT06618235) is a first-in-human, multi-centre trial to assess safety, tolerability and preliminary efficacy of THEO-260 in patients with high-grade serous ovarian or endometrioid cancer.
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 - - SYN-004 Interim blinded safety and ...
Chronic stress fuels cancer by releasing stress mediators that remodel the tumor and stromal cells, promoting immune evasion, angiogenesis, and metastasis. A review in Science Bulletin underscores how ...
You may experience a dull ache or cramping in one or both sides of the lower abdomen, as well as feelings of pressure or fullness. Pain may radiate from the lower abdomen to the back. Ovarian cysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback